Staphylococcal bacteriophage-associated lysin: a lytic agent active against Staphylococcus aureus

Area of Science:

• Microbiology
• Enzymology
• Bacteriology

Background:

• Staphylococcus aureus poses a significant health threat.
• Bacteriophage-derived enzymes offer potential antimicrobial strategies.
• Targeting bacterial cell walls is a key approach for antibacterial agents.

Purpose of the Study:

• To identify and characterize a lytic enzyme released from bacteriophage-infected Staphylococcus aureus.
• To investigate the properties and substrate specificity of this enzyme, termed staphylococcal phage-associated lysin (PAL).
• To explore the potential of PAL as an antimicrobial agent.

Main Methods:

• Partial purification of PAL using ammonium sulfate precipitation and Sephadex G-200 gel filtration.
• Assaying lytic activity against viable staphylococci and purified cell walls.
• Determining optimal activity conditions (pH, temperature) and the effect of reducing agents.
• Investigating enzyme activity against various bacterial species and spheroplast stabilization.

Main Results:

• PAL was released upon lysis of infected S. aureus cells and partially purified.
• Optimal PAL activity was observed at pH 6.5 and 30°C, enhanced by reducing agents.
• PAL exhibited lytic activity against all tested staphylococcal strains and purified cell walls, but not other bacteria.
• PAL demonstrated peptidase activity, producing osmotically stable spheroplasts with polyethylene glycol 4000.

Conclusions:

• Staphylococcal phage-associated lysin (PAL) is a potent enzyme with specific activity against staphylococci.
• PAL's characteristics suggest its potential as a targeted antibacterial agent.
• The ability to stabilize spheroplasts opens avenues for further research and application development.